Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin Choy

Showing results (61-70 of 180) with videos related to

Pageof 18
Sort By:
Oncotarget|April 15, 2015
Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordomaYong Feng, Jacson Shen, Yan Gao, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|December 22, 2015
Clinical and biological significance of PIM1 kinase in osteosarcomaYunfei Liao, Yong Feng, Jacson Shen, et al.
Carcinogenesis|January 1, 2010
The kinase Mirk is a potential therapeutic target in osteosarcomaCao Yang, Diana Ji, Edward J Weinstein, et al.
JACC. Case Reports|January 17, 2025
Atypical Location of Papillary Fibroelastoma in a Patient With Significant Oncologic HistoryAdham Makarem, Patrick Udeh, Carly Liquori, et al.
Plos One|June 4, 2010
Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcomaMichiro Susa, Arun K Iyer, Keinosuke Ryu, et al.
Oncotarget|April 19, 2017
Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cellsYunfei Liao, Lulu Chen, Yong Feng, et al.
European Journal of Cancer (Oxford, England : 1990)|January 7, 2014
Comparison of performance of various tumour response criteria in assessment of regorafenib activity in advanced gastrointestinal stromal tumours after failure of imatinib and sunitinibAtul B Shinagare, Jyothi P Jagannathan, Vikram Kurra, et al.
Genes, Chromosomes & Cancer|November 19, 2025
"Benign" Metastasizing Fibrous Histiocytoma Harboring PRKCD Gene Fusions With Malignant Clinical CourseCharlotte I Wang, Anne B Giersch, Santiago Lozano Calderon, et al.
Molecular Oncology|February 2, 2017
miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivoZhenfeng Duan, Yan Gao, Jacson Shen, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|December 31, 2009
Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expressionZhenfeng Duan, Edwin Choy, G Petur Nielsen, et al.
Pageof 18

Showing results (61-70 of 180) with videos related to

Sort By:
Pageof 18
Oncotarget|April 15, 2015
Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordomaYong Feng, Jacson Shen, Yan Gao, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|December 22, 2015
Clinical and biological significance of PIM1 kinase in osteosarcomaYunfei Liao, Yong Feng, Jacson Shen, et al.
Carcinogenesis|January 1, 2010
The kinase Mirk is a potential therapeutic target in osteosarcomaCao Yang, Diana Ji, Edward J Weinstein, et al.
JACC. Case Reports|January 17, 2025
Atypical Location of Papillary Fibroelastoma in a Patient With Significant Oncologic HistoryAdham Makarem, Patrick Udeh, Carly Liquori, et al.
Plos One|June 4, 2010
Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcomaMichiro Susa, Arun K Iyer, Keinosuke Ryu, et al.
Oncotarget|April 19, 2017
Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cellsYunfei Liao, Lulu Chen, Yong Feng, et al.
European Journal of Cancer (Oxford, England : 1990)|January 7, 2014
Comparison of performance of various tumour response criteria in assessment of regorafenib activity in advanced gastrointestinal stromal tumours after failure of imatinib and sunitinibAtul B Shinagare, Jyothi P Jagannathan, Vikram Kurra, et al.
Genes, Chromosomes & Cancer|November 19, 2025
"Benign" Metastasizing Fibrous Histiocytoma Harboring PRKCD Gene Fusions With Malignant Clinical CourseCharlotte I Wang, Anne B Giersch, Santiago Lozano Calderon, et al.
Molecular Oncology|February 2, 2017
miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivoZhenfeng Duan, Yan Gao, Jacson Shen, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|December 31, 2009
Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expressionZhenfeng Duan, Edwin Choy, G Petur Nielsen, et al.
Pageof 18